A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.

De Jongh, C A

A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients. [electronic resource] - The American journal of medicine May 1986 - 101-11 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0002-9343


Adolescent
Adult
Aged
Agranulocytosis--complications
Amikacin--administration & dosage
Bacterial Infections--drug therapy
Blood Bactericidal Activity--drug effects
Blood Coagulation Disorders--chemically induced
Clinical Trials as Topic
Drug Hypersensitivity--etiology
Drug Synergism
Drug Therapy, Combination
Fever--drug therapy
Hearing Disorders--chemically induced
Humans
Infections--etiology
Kanamycin--analogs & derivatives
Kidney Diseases--chemically induced
Microbial Sensitivity Tests
Middle Aged
Moxalactam--administration & dosage
Neoplasms--complications
Piperacillin--administration & dosage
Random Allocation